169 related articles for article (PubMed ID: 7828615)
1. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi.
Baillet G; Albuquerque L; Chen Q; Poisson M; Delattre JY
Eur J Nucl Med; 1994 Oct; 21(10):1061-6. PubMed ID: 7828615
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
[TBL] [Abstract][Full Text] [Related]
3. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
Beauchesne P; Pedeux R; Boniol M; Soler C
J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
[TBL] [Abstract][Full Text] [Related]
6. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
[TBL] [Abstract][Full Text] [Related]
7. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies.
Le Jeune FP; Dubois F; Blond S; Steinling M
J Neurooncol; 2006 Apr; 77(2):177-83. PubMed ID: 16314957
[TBL] [Abstract][Full Text] [Related]
8. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
[TBL] [Abstract][Full Text] [Related]
9. Presurgical (99m)Tc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours.
Cecchin D; Chondrogiannis S; Della Puppa A; Rotilio A; Zustovich F; Manara R; Gardiman M; Berti F; Zucchetta P; Carollo C; Bui F
Nucl Med Commun; 2009 Sep; 30(9):660-8. PubMed ID: 19561554
[TBL] [Abstract][Full Text] [Related]
10. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
11. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
12. [Is cerebral tomoscintigraphy with 99mTc-MIBI useful in the diagnosis of local recurrence in patients with malignant gliomas?].
Beauchesne P; Soler C; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
Cancer Radiother; 1998; 2(1):42-8. PubMed ID: 9749095
[TBL] [Abstract][Full Text] [Related]
13. [The value of scintigraphic imaging with 99mTc-MIBI for the diagnosis of gliomas].
Stefănescu C; Meignan M; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):99-107. PubMed ID: 9455354
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of 99mTc-MIBI brain SPECT for brain glioma].
Fan YX; Luo RC; Li GP; Huang K
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1184-5. PubMed ID: 15485796
[TBL] [Abstract][Full Text] [Related]
17. Introduction of novel semiquantitative evaluation of (99m)Tc-MIBI SPECT before and after treatment of glioma.
Deltuva VP; Jurkienė N; Kulakienė I; Bunevičius A; Matukevičius A; Tamašauskas A
Medicina (Kaunas); 2012; 48(1):15-21. PubMed ID: 22481370
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
[TBL] [Abstract][Full Text] [Related]
19. Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients.
Naddaf SY; Akisik MF; Aziz M; Omar WS; Hirschfeld A; Masdeu J; Donnenfeld H; Abdel-Dayem HM
Nucl Med Commun; 1998 Jan; 19(1):47-53. PubMed ID: 9515546
[TBL] [Abstract][Full Text] [Related]
20. Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma.
Roshdy E; ElNaggar M; Atta H; Kandeel A; Abdel-Wanis M; Abd Elbadee OM; Abdelhafez YG; Mohamed Y
Nucl Med Commun; 2021 Jun; 42(6):625-632. PubMed ID: 33625186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
